Not applicableStudy completedNCT00002807What this trial is testingRadiation or Observation Only in Endometrial Cancer Who Have Undergone SurgeryWho this might be right forEndometrial Cancer NCIC Clinical Trials Group 116
Testing effectiveness (Phase 2)Ended earlyNCT01793636What this trial is testingA Study Comparing AZD2014 vs Everolimus in Patients With Metastatic Renal CancerWho this might be right forMetastatic Clear Cell Renal Carcinoma Queen Mary University of London 49
Testing effectiveness (Phase 2)Study completedNCT05130515What this trial is testingAnlotinib Combined With Niraparib Dual Therapy in Platinum-resistant Recurrent Ovarian Clear Cell Carcinoma.Who this might be right forPlatinum-resistant Recurrent Clear Cell Ovarian Cancer Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 6
Testing effectiveness (Phase 2)UnknownNCT00301990What this trial is testingBevacizumab and Interleukin-2 in Treating Patients With Metastatic Kidney CancerWho this might be right forKidney Cancer Jonsson Comprehensive Cancer Center 65
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07578025What this trial is testingZanzalintinib and MO-03 for the Treatment of Metastatic Renal Cell Cancer After Progression on ImmunotherapyWho this might be right forMetastatic Clear Cell Renal Cell CarcinomaStage IV Renal Cell Cancer AJCC v8 City of Hope Medical Center 34
Testing effectiveness (Phase 2)Active Not RecruitingNCT03634540What this trial is testingA Trial of Belzutifan (PT2977, MK-6482) in Combination With Cabozantinib in Patients With Clear Cell Renal Cell Carcinoma (ccRCC) (MK-6482-003)Who this might be right forRenal Cell Carcinoma (RCC)Clear Cell Renal Cell Carcinoma (ccRCC)Kidney Cancer+6 more Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 118
Testing effectiveness (Phase 2)Ended earlyNCT02771626What this trial is testingStudy CB-839 in Combination With Nivolumab in Patients With Melanoma, Clear Cell Renal Cell Carcinoma (ccRCC) and Non-Small Cell Lung Cancer (NSCLC)Who this might be right forClear Cell Renal Cell Carcinoma (ccRCC)MelanomaNon-small Cell Lung Cancer (NSCLC) Calithera Biosciences, Inc 118
Testing effectiveness (Phase 2)UnknownNCT05879510What this trial is testing68Ga-NY104 PET/CT for the Detection of Clear Cell Renal Cell Carcinoma in Presurgical Patients With Renal MassesWho this might be right forClear Cell Renal Cell Carcinoma Peking Union Medical College Hospital 63
Very early researchEnded earlyNCT02885649What this trial is testingEnzalutamide Before Surgery in Treating Patients With Kidney CancerWho this might be right forClear Cell Renal Cell CarcinomaStage I Renal Cell Cancer Rutgers, The State University of New Jersey 3
Testing effectiveness (Phase 2)Study completedNCT00008138What this trial is testingS0009 Combination Chemo and Surgery in Stage III or Stage IV Ovarian CancerWho this might be right forFallopian Tube CancerOvarian CancerPeritoneal Cavity Cancer SWOG Cancer Research Network 62
Early research (Phase 1)Ended earlyNCT05121948What this trial is testingHC-7366 to Establish the Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D)Who this might be right forSquamous Cell Carcinoma of Head and NeckColo-rectal CancerNon Small Cell Lung Cancer+3 more HiberCell, Inc. 35
Large-scale testing (Phase 3)Active Not RecruitingNCT02839707What this trial is testingPegylated Liposomal Doxorubicin Hydrochloride With Atezolizumab and/or Bevacizumab in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal CancerWho this might be right forFallopian Tube High Grade Serous AdenocarcinomaOvarian High Grade Serous AdenocarcinomaOvarian Seromucinous Carcinoma+16 more National Cancer Institute (NCI) 444
Early research (Phase 1)Ended earlyNCT06052852What this trial is testingStudy of BDC-3042 as Single Agent and in Combination With Cemiplimab in Patients With Advanced MalignanciesWho this might be right forTriple Negative Breast CancerClear Cell Renal Cell CarcinomaOvarian Cancer+4 more Bolt Biotherapeutics, Inc. 17
Early research (Phase 1)Active Not RecruitingNCT05581004What this trial is testingEvaluate the Safety, Pharmacokinetics, and Activity of Enzelkitug as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid TumorsWho this might be right forLocally Advanced or Metastatic Solid TumorsNSCLCHNSCC+9 more Genentech, Inc. 165
Large-scale testing (Phase 3)Study completedNCT00002493What this trial is testingRadiation Therapy Compared With Combination Chemotherapy in Treating Patients With Advanced Endometrial CancerWho this might be right forEndometrial CancerPsychosocial Effects of Cancer and Its Treatment Gynecologic Oncology Group
Large-scale testing (Phase 3)UnknownNCT01099423What this trial is testingImmediate Surgery or Surgery After Sunitinib Malate in Treating Patients With Metastatic Kidney CancerWho this might be right forKidney Cancer European Organisation for Research and Treatment of Cancer - EORTC 99
Not applicableLooking for participantsNCT06088134What this trial is testingContrast-enhanced CT-based Deep Learning Model for Preoperative Prediction of Disease-free Survival (DFS) in Localized Clear Cell Renal Cell Carcinoma (ccRCC)Who this might be right forClear Cell Renal Cell CarcinomaPrognostic Cancer ModelRecurrent Renal Cell Cancer Mingzhao Xiao 800
Not applicableWithdrawnNCT04680416What this trial is testingTissue Collection to ID TCRs From Renal Clear Cell Carcinoma Patients Responding to Immune Checkpoint InhibitorsWho this might be right forRenal Clear Cell Carcinoma TScan Therapeutics, Inc.
Not applicableWithdrawnNCT04609800What this trial is testingStudy on the Utilization of Cabozantinib in Adult Patients With Advanced or Metastatic Renal Cell Carcinoma (RCC) in 2nd Line Treatment Following Prior Vascular Endothelial Growth Factor (VEGF)-Targeted Therapy Under Real-real Life Clinical Setting in France.Who this might be right forRenal Cell Carcinoma Ipsen
Early research (Phase 1)Study completedNCT02262455What this trial is testingEffects of STM 434 Alone or in Combination With Liposomal Doxorubicin in Patients With Ovarian Cancer or Other Advanced Solid TumorsWho this might be right forOvarian CancerFallopian Tube CancerEndometrial Cancer+1 more Santa Maria Biotherapeutics 32